Bychowski Jakub, Michalski Tomasz, Sobiczewski Wojciech, Jaguszewski Miłosz, Gruchała Marcin
1st Department of Cardiology, Medical University of Gdansk, Gdansk, Poland.
Front Cardiovasc Med. 2025 Apr 16;12:1522661. doi: 10.3389/fcvm.2025.1522661. eCollection 2025.
The most reliable care quality indicators for STEMI patients undergoing primary percutaneous coronary intervention (pPCI) include onset-to-door time (OTDT), time from admission to wire crossing and in-hospital mortality.
Our study aimed to evaluate the impact of the COVID-19 pandemic on these selected care quality indicators in pre-pandemic and pandemic groups of STEMI patients.
This single-centre, retrospective study, enrolled 480 STEMI patients, aged 63.59 ± 12.44 years treated with pPCI across two time frames: pre-pandemic ( = 331) and pandemic ( = 149). The evaluation criteria included OTDT, time from admission to PCI-mediated reperfusion, in-hospital mortality, and predictors of time delays.
Our study revealed a significant increases in OTDT (median 3 h; IQR 1.5-12.0 vs. median 5 h; IQR 2.0-24.0, = 0.011) and time from admission to wire crossing (median 92 min; IQR 65.0-187.0 vs. median 115.0; IQR 73.0-233.0, = 0.025), in the COVID-19 pandemic group of STEMI patients, compared to the pre-pandemic subset. We also observed an increase in in-hospital mortality (7.85% vs. 14.09%, = 0.033) and incidence of cardiogenic shock/cardiac arrest (16.62% vs. 26.85%, = 0.009). Additionally, the proportion of patients with prolonged OTDT (24.45% vs. 35.71%, = 0.019) and extended time from admission to PCI-mediated reperfusion (51.96% vs. 65.77%, = 0.005) increased during the pandemic period.
The study's results indicated prolonged OTDT and admission-to-wire crossing times, increased in-hospital mortality, and the higher frequency of cardiogenic shock/cardiac arrest during the COVID-19 pandemic. These findings demonstrate the negative impact of the pandemic on treatment times and outcomes for patients diagnosed with STEMI.
对于接受直接经皮冠状动脉介入治疗(pPCI)的ST段抬高型心肌梗死(STEMI)患者,最可靠的护理质量指标包括发病至入院时间(OTDT)、入院至导丝通过时间和院内死亡率。
我们的研究旨在评估2019冠状病毒病大流行对STEMI患者大流行前和大流行组中这些选定护理质量指标的影响。
这项单中心回顾性研究纳入了480例STEMI患者,年龄为63.59±12.44岁,在两个时间段接受pPCI治疗:大流行前(n = 331)和大流行期间(n = 149)。评估标准包括OTDT、入院至PCI介导的再灌注时间、院内死亡率和时间延迟的预测因素。
我们的研究显示,与大流行前亚组相比,COVID-19大流行组STEMI患者的OTDT(中位数3小时;IQR 1.5 - 12.0 vs.中位数5小时;IQR 2.0 - 24.提示时间延迟的预测因素。
我们的研究显示,与大流行前亚组相比,COVID-19大流行组STEMI患者的OTDT(中位数3小时;IQR 1.5 - 12.0 vs.中位数5小时;IQR 2.0 - 24.0,P = 0.011)和入院至导丝通过时间(中位数92分钟;IQR 65.0 - 187.0 vs.中位数115.0;IQR 73.0 - 233.0,P = 0.025)显著增加。我们还观察到院内死亡率增加(7.85% vs. 14.09%,P = 0.033)和心源性休克/心脏骤停发生率增加(16.62% vs. 26.85%,P = 0.009)。此外,在大流行期间,OTDT延长的患者比例(24.45% vs. 35.71%,P = 0.019)和入院至PCI介导的再灌注时间延长的患者比例(51.96% vs. 65.77%,P = 0.005)增加。
研究结果表明,在2019冠状病毒病大流行期间,OTDT和入院至导丝通过时间延长,院内死亡率增加,心源性休克/心脏骤停频率更高。这些发现证明了大流行对STEMI确诊患者的治疗时间和结局产生了负面影响。